IL103920A - Pharmaceutical preparations for inhibiting the growth of cancer cells and use of lycopene for the preparation thereof - Google Patents

Pharmaceutical preparations for inhibiting the growth of cancer cells and use of lycopene for the preparation thereof

Info

Publication number
IL103920A
IL103920A IL10392092A IL10392092A IL103920A IL 103920 A IL103920 A IL 103920A IL 10392092 A IL10392092 A IL 10392092A IL 10392092 A IL10392092 A IL 10392092A IL 103920 A IL103920 A IL 103920A
Authority
IL
Israel
Prior art keywords
lycopene
inhibiting
growth
cancer cells
preparation
Prior art date
Application number
IL10392092A
Other languages
English (en)
Other versions
IL103920A0 (en
Original Assignee
Makhteshim Chem Works Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=11064278&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IL103920(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Makhteshim Chem Works Ltd filed Critical Makhteshim Chem Works Ltd
Priority to IL10392092A priority Critical patent/IL103920A/xx
Publication of IL103920A0 publication Critical patent/IL103920A0/xx
Priority to CA002109750A priority patent/CA2109750A1/en
Priority to ZA938791A priority patent/ZA938791B/xx
Priority to AT93203295T priority patent/ATE225168T1/de
Priority to EP93203295A priority patent/EP0600544B1/en
Priority to ES93203295T priority patent/ES2181682T3/es
Priority to DK93203295T priority patent/DK0600544T3/da
Priority to DE69332350T priority patent/DE69332350T2/de
Priority to JP5296934A priority patent/JPH06227970A/ja
Priority to CNB931216370A priority patent/CN1142774C/zh
Priority to MX9307509A priority patent/MX9307509A/es
Priority to KR1019930025649A priority patent/KR100301682B1/ko
Priority to AU52014/93A priority patent/AU679467B2/en
Priority to US08/532,263 priority patent/US5827900A/en
Publication of IL103920A publication Critical patent/IL103920A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/01—Hydrocarbons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/81—Solanaceae (Potato family), e.g. tobacco, nightshade, tomato, belladonna, capsicum or jimsonweed
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Medical Informatics (AREA)
  • Mycology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Engineering & Computer Science (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IL10392092A 1992-11-30 1992-11-30 Pharmaceutical preparations for inhibiting the growth of cancer cells and use of lycopene for the preparation thereof IL103920A (en)

Priority Applications (14)

Application Number Priority Date Filing Date Title
IL10392092A IL103920A (en) 1992-11-30 1992-11-30 Pharmaceutical preparations for inhibiting the growth of cancer cells and use of lycopene for the preparation thereof
CA002109750A CA2109750A1 (en) 1992-11-30 1993-11-23 Method and pharmaceutical preparations for reducing the activity of cells
ZA938791A ZA938791B (en) 1992-11-30 1993-11-24 Method and pharmaceutical preparations for reducing the activity of cells.
DE69332350T DE69332350T2 (de) 1992-11-30 1993-11-25 Verwendung von Lycopen zur Verminderung der Zellaktivität, insbesondere von Krebszellen, sowie entsprechende pharmazeutische Zubereitungen
DK93203295T DK0600544T3 (da) 1992-11-30 1993-11-25 Anvendelse af lycopen til at reducere aktivitet af celler, især af cancerceller, og farmaceutiske præparater
ES93203295T ES2181682T3 (es) 1992-11-30 1993-11-25 Utilizacion de licopeno para reducir la actividad de las celulas, en particular celulas cancerosas y preparaciones farmaceuticas.
EP93203295A EP0600544B1 (en) 1992-11-30 1993-11-25 Use of lycopene for reducing the activity of cells, especially of cancer cells, and pharmaceutical preparations
AT93203295T ATE225168T1 (de) 1992-11-30 1993-11-25 Verwendung von lycopen zur verminderung der zellaktivität, insbesondere von krebszellen, sowie entsprechende pharmazeutische zubereitungen
JP5296934A JPH06227970A (ja) 1992-11-30 1993-11-26 細胞の活性を減じるための方法及び医薬製剤
CNB931216370A CN1142774C (zh) 1992-11-30 1993-11-27 降低细胞活性的方法和药物制剂
MX9307509A MX9307509A (es) 1992-11-30 1993-11-29 Metodo y preparacion farmaceutica para reducir la actividad de las celulas.
KR1019930025649A KR100301682B1 (ko) 1992-11-30 1993-11-29 세포활동을감소시키는약제조성물
AU52014/93A AU679467B2 (en) 1992-11-30 1993-11-29 Method and pharmaceutical preparations for reducing the activity of cells
US08/532,263 US5827900A (en) 1992-11-30 1995-09-22 Method and pharmaceutical preparations for reducing the activity of cells

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IL10392092A IL103920A (en) 1992-11-30 1992-11-30 Pharmaceutical preparations for inhibiting the growth of cancer cells and use of lycopene for the preparation thereof

Publications (2)

Publication Number Publication Date
IL103920A0 IL103920A0 (en) 1993-04-04
IL103920A true IL103920A (en) 2000-07-26

Family

ID=11064278

Family Applications (1)

Application Number Title Priority Date Filing Date
IL10392092A IL103920A (en) 1992-11-30 1992-11-30 Pharmaceutical preparations for inhibiting the growth of cancer cells and use of lycopene for the preparation thereof

Country Status (14)

Country Link
US (1) US5827900A (da)
EP (1) EP0600544B1 (da)
JP (1) JPH06227970A (da)
KR (1) KR100301682B1 (da)
CN (1) CN1142774C (da)
AT (1) ATE225168T1 (da)
AU (1) AU679467B2 (da)
CA (1) CA2109750A1 (da)
DE (1) DE69332350T2 (da)
DK (1) DK0600544T3 (da)
ES (1) ES2181682T3 (da)
IL (1) IL103920A (da)
MX (1) MX9307509A (da)
ZA (1) ZA938791B (da)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996019217A1 (en) * 1994-12-22 1996-06-27 Henkel Corporation Pharmaceutical compositions comprising lycopene
US6262109B1 (en) 1995-12-22 2001-07-17 Henkel Corporation Methods of preventing and/or treating high serum levels of cholesterol and/or lipids
JP2750281B2 (ja) * 1995-06-15 1998-05-13 睦憲 藤原 高コレステロール血症治療剤
IT1283143B1 (it) * 1996-07-12 1998-04-07 Indena Spa Metodo di estrazione del licopene ed estratti che lo contengono
US20060160702A1 (en) * 1998-02-23 2006-07-20 Etienne Soudant Compositions comprising anti-proliferative agents and use thereof
GB9808796D0 (en) 1998-04-24 1998-06-24 Rowett Research Services Limit Antithrombotic agents
GB9821671D0 (en) 1998-10-05 1998-12-02 Muhlbauer Roman C Plant extracts for the treatment of increased bone resorption
IL129442A0 (en) * 1999-04-14 2000-02-29 Lycored Natural Prod Ind Ltd Compounds useful in reducing the level of insulin like growth factor-1 (IGF-1) in blood
US6482447B2 (en) 1999-09-10 2002-11-19 Glenn Braswell Method and composition for the treatment of benign prostate hypertrophy (BPH) and prevention of prostate cancer
IL135335A (en) * 2000-03-29 2013-12-31 Lycored Natural Prod Ind Ltd Use of Carotenoids in Preparing Pharmaceuticals to Prevent Adverse Effects from Hormones and Pharmaceuticals Containing Carotenoids
US6989161B2 (en) * 2000-06-12 2006-01-24 Access Business Group International Llc Phytonutrient nutritional supplement
IL146449A0 (en) * 2001-11-12 2002-07-25 Lycored Natural Prod Ind Ltd Method and pharmaceutical preparations for reducing the activity of cells
EP1314438A1 (en) * 2001-11-23 2003-05-28 Nutricia N.V. Anti-proliferative composition
US20040001898A1 (en) * 2002-06-26 2004-01-01 Armand Malnoe Compositions and methods for detoxification and cancer prevention
CA2625433A1 (en) * 2005-10-11 2007-04-19 Lycored Ltd. Carotenoid oxidation products as chemopreventive and chemotherapeutic agents
WO2007050673A2 (en) * 2005-10-25 2007-05-03 University Of Florida Cyclin dependent kinase inhibitors
TW200738227A (en) * 2006-04-03 2007-10-16 Panatoz Corp One kind of multi-carotenoids and its administration
US8221803B1 (en) 2007-06-25 2012-07-17 OncoNatural Solutions, Inc. Composition for prostate health
CN101978986A (zh) * 2010-10-21 2011-02-23 蒋科罡 一种治疗肿瘤的中药制剂及制法
CN101961354A (zh) * 2010-10-21 2011-02-02 蒋科罡 一种配用蜂王浆治疗肿瘤的中药及制法
CN102894421A (zh) * 2011-07-24 2013-01-30 江西食方食坊中药食品有限公司 一种预防前列腺疾病的番杞饮料及其制备方法
CN107049998A (zh) * 2016-09-20 2017-08-18 南华大学附属第二医院 番茄红素顺式异构体在制备卵巢癌治疗药物中的应用
IT201700005649A1 (it) 2017-01-19 2018-07-19 Associazione Oncologica Milanese Amo La Vita Onlus Uso di derivati di carotenoidi per ridurre la tossicità ed aumentare l’efficacia di trattamenti antitumorali anti-egfr
CN109172552A (zh) * 2018-07-18 2019-01-11 浙江格蕾斯生物科技有限公司 男性前列腺癌植物防治药物及制取方法
KR102220400B1 (ko) * 2019-03-06 2021-02-26 파이룽 머시너리 밀 코., 엘티디. 2개의 노크-오버로 형성된 비트 사이에 조절 가능한 간극을 갖는 횡편기 구조

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1509587A (en) * 1975-08-19 1978-05-04 Ajinomoto Kk Anti-tumour composition
FR2558372B1 (fr) * 1984-01-25 1987-08-07 Oreal Composition medicamenteuse pour le traitement de l'acne
US5008295A (en) * 1987-07-30 1991-04-16 Lion Corporation Method inhibiting the growth of cancer cells
DE69018117T2 (de) * 1989-04-21 1995-10-26 Kirin Brewery Zur Synthese von Karotinoiden verwendbare DNA-Sequenzen.
FR2664164A1 (fr) * 1990-07-04 1992-01-10 Texinfine Patrinove Composition dermatologique ou cosmetique.

Also Published As

Publication number Publication date
CN1095589A (zh) 1994-11-30
ES2181682T3 (es) 2003-03-01
JPH06227970A (ja) 1994-08-16
IL103920A0 (en) 1993-04-04
EP0600544B1 (en) 2002-10-02
DK0600544T3 (da) 2002-11-18
AU5201493A (en) 1994-06-09
US5827900A (en) 1998-10-27
DE69332350T2 (de) 2003-06-18
CA2109750A1 (en) 1994-05-31
MX9307509A (es) 1997-06-28
ATE225168T1 (de) 2002-10-15
KR100301682B1 (ko) 2001-10-22
DE69332350D1 (de) 2002-11-07
KR940011010A (ko) 1994-06-20
ZA938791B (en) 1994-10-03
CN1142774C (zh) 2004-03-24
EP0600544A1 (en) 1994-06-08
AU679467B2 (en) 1997-07-03

Similar Documents

Publication Publication Date Title
IL103920A (en) Pharmaceutical preparations for inhibiting the growth of cancer cells and use of lycopene for the preparation thereof
ZA885192B (en) Pharmaceutical preparations
AU4697393A (en) Pharmaceutical and/or cosmetic preparation and the use of the preparation
CA2033725A1 (en) Pharmaceutical and cosmetic compositions containing a salt of cholanic acid
CA2068324A1 (en) Metal-peptide compositions and methods for stimulating hair growth
TW234691B (da)
AU5022593A (en) Prodrugs, their preparation and use as pharmaceuticals
HUT41221A (en) Insecticide and acaricide compositions further process for preparing phenoxy-alkyl-amino-pyridine derivatives as active ingredients thereof
RU94046044A (ru) Новые 7 бета -замещенные 4-аза- 5 альфа -холестан-оны в качестве ингибиторов 5 альфа -редуктазы, фармацевтическая композиция на их основе, способ ее получения
HU9202044D0 (en) Method for producing 4-phenyl-piperidine-4-carbixamide derivatives and pharmaceutical preparatives containing these compounds as active agents
EP0137543A3 (en) Pharmaceutical composition for the therapy of peripheral arteriopathies
AU5938398A (en) Pour-on formulations containing polymeric material, glycols and glycerides
ES2194055T3 (es) Nuevo uso de prostaglandinas.
IT1190361B (it) Composizione farmaceutica in crema per uso dermale ed oftalmico
AU591046B2 (en) Physiologically active agent for agricultural use
RU94040865A (ru) Производные пептида и их терапевтически приемлемые соли, способ их получения, фармацевтическая и косметическая композиция с антивирусной активностью
EP0351876A3 (en) Composition for potentiating vaccination effect
HK8994A (en) Medicament for treatment of pregnancy-induced hypertension
EP0132772A3 (en) Fr-900216 substance obtainable by cultivating atcc 20577 for use as an active therapeutic substance and pharmaceutical antitumor composition comprising fr-900216 substance
CA2100314A1 (en) Pharmaceutical Composition for the Treatment of Chronic Skin Ulcers
RU93053031A (ru) Способ снижения активности клеток, способ подавления раковых клеток и фармацевтические препараты для снижения активности клеток, способ лечения
IT1254256B (it) Derivati di idroisochinolina
HUT64689A (en) Cosmetic preparations containing medicinal plant extracts as active ingredients
ITMI921151A1 (it) Composti terapeuticamente attivi, particolarmente ad attivita' nootropica e procedimento per la loro preparazione
TW225993B (en) A composition prevention hair loss and promoting hair growth and its usage

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed
KB Patent renewed
KB Patent renewed
EXP Patent expired